ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Geriatric Medicine

Top Geriatric Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TWINKLE PATEL MD

Geriatric Medicine

33,945

$5,814

285
276 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 26%

$0
Average prescription price

Avg: $50

ARUN PATEL MD

Geriatric Medicine

19,708

$711K

488
420 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $50

ALAN SMITH MD

Geriatric Medicine

19,317

$1.03M

494
476 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $50

BRYANT NGUYEN M.D.

Geriatric Medicine

16,727

$895K

644
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $50

NASEM SAYEGH M.D.

Geriatric Medicine

12,225

$1.06M

602
442 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 26%

$87
Average prescription price

Avg: $50

MICHAEL DOLAMORE MD

Geriatric Medicine

11,103

$540K

209
200 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $50

ROKSOLANA KUCHMA MD

Geriatric Medicine

10,358

$598K

181
146 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $50

RICHARD CONWAY M.D.

Geriatric Medicine

9,093

$395K

320
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $50

SHAWN BERKOWITZ MD

Geriatric Medicine

8,554

$407K

254
188 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $50

ANNIE MATHAI MD

Geriatric Medicine

8,481

$548K

618
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $50

JOSEPH BOOTH MD

Geriatric Medicine

7,483

$627K

325
288 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$84
Average prescription price

Avg: $50

SEEMA RIZVI MD

Geriatric Medicine

7,351

$403K

304
252 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $50

GLEDA BALDINI MD

Geriatric Medicine

7,247

$371K

706
145 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

2%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $50

LYDIA ROLITA M.D.

Geriatric Medicine

6,527

$401K

509
504 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $50

EUGENE STEINBERG M.D.

Geriatric Medicine

6,508

$402K

158
142 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $50

ALBERT WINYARD MD

Geriatric Medicine

6,429

$446K

318
245 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $50

EDGAR PIMENTEL D.O.

Geriatric Medicine

6,032

$391K

228
179 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $50

JOHN REYES M.D.

Geriatric Medicine

5,560

$366K

382
344 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $50

MARGUERITE COPPENS M.D.

Geriatric Medicine

5,212

$269K

136
136 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $50

FLORIDA OLIVIERI MD

Geriatric Medicine

5,178

$255K

360
360 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $50

PAUL CAVALUZZI D.O.

Geriatric Medicine

5,154

$263K

101
92 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $50

ANDRE SERRETTE MD

Geriatric Medicine

4,737

$271K

287
238 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $50

BRIAN DELANEY M.D.

Geriatric Medicine

4,620

$316K

176
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $50

AMANDEEP PAL M.D.

Geriatric Medicine

4,597

$294K

533
349 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $50

HOWARD ORKIN M.D..

Geriatric Medicine

4,141

$271K

242
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank